Related Experiment Video
Updated: Aug 8, 2026

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
Published on: May 15, 2019
Antiglucocoticoid treatments for depression
1Department of Psychiatry, University of British Columbia, Vancoover, BC Canada. alyoung@interchange.ubc.ca
Antiglucocorticoid treatments show promise for depression by targeting the hypothalamic-pituitary-adrenal (HPA) axis. Lowering cortisol or blocking its effects may improve depressive symptoms and cognitive function.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Pharmacology
Background:
- Hypothalamic-pituitary-adrenal (HPA) axis dysfunction and hypercortisolaemia are common in bipolar and unipolar depression.
- Impaired glucocorticoid receptor negative feedback may contribute to depressive symptoms and neurocognitive deficits.
Purpose of the Study:
- To review literature on antiglucocorticoid treatments for depression.
- To explore strategies counteracting elevated cortisol levels.
Main Methods:
- Selective literature review.
Main Results:
- Research focuses on strategies to counteract elevated cortisol and restore HPA axis integrity.
- Preclinical and clinical studies indicate potential therapeutic benefits.
Conclusions:
- Lowering circulating cortisol or using glucocorticoid antagonists may improve depressive symptoms.
- These approaches may also enhance neurocognitive function in depressed individuals.
- Up-regulation of glucocorticoid receptors is a potential mechanism of action.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Psychosis: Goals of Pharmacotherapy
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
